Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PomdoctorPOM +4.66%20 Forward Dividend Yield % is 0.00% as of Aug. 13, 2026. GuruFocus rates POM with a GF Score™ of 20/100. The stock has 7 warning signs investors should review. Among 278 Healthcare Providers & Services companies, Pomdoctor ranks worse than 359711.87% on this metric.
As of today (2026-08-13), the Forward Annual Dividend Yield of Pomdoctor is 0.00%.
As of today (2026-08-13), the Trailing Annual Dividend Yield of Pomdoctor is 0.00%.
POM's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.415 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
POM vs BLMH, HEWA, PMHS: Forward Dividend Yield % Comparison
For the Pharmaceutical Retailers subindustry, Pomdoctor's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pomdoctor Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pomdoctor's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Pomdoctor's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Pomdoctor (POM) has a Forward Dividend Yield % of 0.00% as of Aug. 13, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Pomdoctor and its competitors. According to the industry distribution chart, Pomdoctor ranks #999999 out of 278 companies in the Healthcare Providers & Services industry.
Is Pomdoctor's Forward Dividend Yield % too high?
Pomdoctor's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Pomdoctor ranks #999999 out of 278 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pomdoctor has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Pomdoctor's Forward Dividend Yield % compare to BLMH and HEWA?
According to the Healthcare Providers & Services industry distribution chart, Pomdoctor ranks #999999 out of 278 companies for Forward Dividend Yield %. This places Pomdoctor in the lower half of its industry. The industry median Forward Dividend Yield % is 2.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.42, based on 278 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Pomdoctor and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pomdoctor's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pomdoctor stock overvalued right now?
Pomdoctor (POM) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Pomdoctor's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Pomdoctor (POM), the current Forward Dividend Yield % is 0.00% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
20GF Score
Get the complete analysis for POM
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POM has been successfully added to your 
